Elevance Health shareholders elect directors, approve say-on-pay, reject DEI proposal

Elevance Health, Inc.

Directors DeVore (185.8M for), Jallal (180.8M for), Schneider (184.6M for) elected to three-year terms.
Advisory vote on executive compensation approved with 173.96M for vs. 15.52M against.
Ratification of Ernst & Young LLP as auditor for 2025 passed with 178.09M for.
Shareholder DEI effectiveness report proposal defeated: 160.69M against, 26.24M for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.